Growth of a variety of human tumor cell lines is inhibited by interferon-y (IFN-,y) in vitro. This mechanism is not well understood. The present experiments identify two separate mechanisms which account for the growth inhibitory activity of IFN-'y. Cell lines most sensitive to IFN-'y (inhibited by 10-30 U/ml IFN-y in 3 d) were stimulated by IFN-'y to oxidize tryptophan in media to kynurenine and completely eliminated tryptophan from the culture media after 48-72 h. Addition of L-tryptophan, but not other aromatic amino acids, other essential amino acids, or D-tryptophan, prevented inhibition of cell growth by IFN-'y. The amount of IFN-'y required to yield 50% inhibition of cell growth was directly related to the concentration of L-tryptophan in culture media and increased from -3 to 600 U/ml as the concentration of tryptophan in the media was increased from 25 to 1,000 MM. By contrast, inhibition of growth of the cell lines, BT20 and HT29, was not prevented by addition of tryptophan. Inhibition by IFN-y (100-300 U/ml after 5-6 d) was, however, completely prevented by addition of two inhibitors of adenosine diphosphate-ribosyl transferase (ADP-RT), 3-aminobenzamide or nicotinamide. Activity of ADP-RT was increased in these cell lines after addition of IFN-y. ADP-RT catalyzes the incorporation of the ADP moiety of nicotinamide adenine dinucleotide (NAD) into proteins and causes depletion of intracellular NAD. All tumor cell lines tested had reduced levels of intracellular NAD after treatment with IFN-'y and loss of NAD preceded inhibition of cell growth by 12-24 h. Inhibitors of IFN-y-mediated inhibition of cell growth prevented loss of levels of intracellular NAD. Generation of reactive oxygen species lead to DNA strand breaks which result in activation of ADP-RT. Increased DNA strand breaks were induced in BT20 and HT29 cells but not ME180 and A549 celIs after culture with IFN-'y. The two enzymes known to catalyze the decyclization of tryptophan to kynurenine require superoxide anion for activity. 
IFN-'y. Cell lines most sensitive to IFN-'y (inhibited by 10-30 U/ml IFN-y in 3 d) were stimulated by IFN-'y to oxidize tryptophan in media to kynurenine and completely eliminated tryptophan from the culture media after h. Addition of L-tryptophan, but not other aromatic amino acids, other essential amino acids, or D-tryptophan, prevented inhibition of cell growth by IFN-'y. The amount of IFN-'y required to yield 50% inhibition of cell growth was directly related to the concentration of L-tryptophan in culture media and increased from -3 to 600 U/ml as the concentration of tryptophan in the media was increased from 25 to 1,000 MM. By contrast, inhibition of growth of the cell lines, BT20 and HT29, was not prevented by addition of tryptophan. Inhibition by IFN-y (100-300 U/ml after 5-6 d) was, however, completely prevented by addition of two inhibitors of adenosine diphosphate-ribosyl transferase (ADP-RT), 3-aminobenzamide or nicotinamide. Activity of ADP-RT was increased in these cell lines after addition of IFN-y. ADP-RT catalyzes the incorporation of the ADP moiety of nicotinamide adenine dinucleotide (NAD) into proteins and causes depletion of intracellular NAD. All tumor cell lines tested had reduced levels of intracellular NAD after treatment with IFN-'y and loss of NAD preceded inhibition of cell growth by 12-24 h. Inhibitors of IFN-y-mediated inhibition of cell growth prevented loss of levels of intracellular NAD. Generation of reactive oxygen species lead to DNA strand breaks which result in activation of ADP-RT. Increased DNA strand breaks were induced in BT20 and HT29 cells but not ME180 and A549 celIs after culture with IFN-'y. The two enzymes known to catalyze the decyclization of tryptophan to kynurenine require superoxide anion for activity. Increased amounts of superoxide anion were released from ME180 and A549 cells after culture with IFN-y. Reduced oxygen concentration decreased the ability of IFN-'y to inhibit tumor cell growth in vitro. Intracellular glutathione has been shown to protect cells against oxidative damage by various agents. Elevation or reduction of intracellular glutathione concentrations Introduction Interferons represent a class of proteins with various biological properties (1, 2) . These include the ability to inhibit intracellular replication of viruses and certain parasites (3) , the ability to inhibit replication ofcertain types oftumor cells in vitro (4) , and the ability to modulate immune responses in vitro and in vivo in a positive or negative manner (2) . The various activities of interferons have been suggested to be associated with changes in the expression of certain genes and proteins such as double-stranded RNA-dependent protein kinases, 2',5'-oligoadenylate synthetase, ribonuclease L, or certain oncogene mRNAs (5) . Additionally, interferons have been shown to alter intracellular concentrations of cyclic 3',5' adenosine monophosphate, phosphorylation of ribosome-associated proteins and intracellular cytoskeletal structure (6) .
Of the interferons, interferon-y (IFN-y) is thought to be a more effective immunomodulatory agent and a more effective inhibitor of division of certain tumor cells in vitro than other interferons (2, 4) . The response of human tumor cell lines to IFN-y is heterogeneous. Some tumor cell lines are relatively sensitive to growth inhibition by IFN-'y whereas others are less sensitive and some cell lines are totally resistant. Further, the activity of IFN-y against growth of tumor cell lines in vivo is not as great as the activity which has been observed in vitro (7) . Unifying mechanisms are not available to explain these apparent differences. Recent data have emerged to suggest that one mechanism ofIFN-y-mediated growth inhibition is the stimulation of cellular oxidation of tryptophan by indoleamine 2,3-dioxygenase (8, 9) . However, certain other tumor cell lines growth inhibited by IFN-y do not increase tryptophan catabolism (9, 10).
One possible difference which could influence the response of tumor cells to IFN-y in vitro or in vivo is the oxygen tension. Solid tumors in vivo exist in significantly lower oxygen tension than found in monolayers of cells in tissue culture (1 1) . Results presented here demonstrate that: (a) reduced oxygen tension reduces the antiproliferative activity of IFN-'y in vitro; (b) increases or decreases in intracellular glutathione concentration decrease or increase, respectively, sensitivity of tumor cell lines to growth inhibition by IFN-'y, and (c) two distinct mechanisms have been identified which account for the inhibitory activity of IFN-'y against several different tumor cell lines. One mechanism is stimulation ofcellular catabolism oftryptophan, and the second is stimulation ofcellular catabo-lism of nicotinamide adenine dinucleotide (NAD) by adenosine diphosphate-ribosyl transferase (ADP-RT)' (12) . Two enzymes known to catabolize tryptophan are tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase (13) . Both enzymes require superoxide anion for activity. One mechanism of activation of ADP-RT is through generation of DNA strand breaks. A wide variety of agents capable of producing oxidizing species have been shown to mediate DNA damage by this mechanism (14) . These observations may Amino acid analysis. Culture media (2 ml) were clarified with O.2-,um filters and analyzed with an Aminoanalyzer (Hewlett-Packard Co., Palo Alto, CA) by reversed-phase high-performance liquid chromatography. Amino acids were precolumn derivatized with o-phthaldialdehyde, and detected by fluorescence (16) . Amino acids were identified and quantitated by comparison of retention times and peak heights to known standards.
Kynurenine production. After culture of tumor cells for 48 h in the presence or absence of IFN-y, culture media was replaced with RPMI media without phenol red, vitamins or amino acids but with 100-500 MM L-tryptophan. Culture fluids were harvested after 6-24 h of incubation, clarified by filtration, and analyzed for content of tryptophan and kynurenine on an amino acid analyzer (Beckman Instruments, Inc., Palo Alto, CA). Tryptophan and kynurenine were precolumn derivatized with ninhydrin and identified and quantitated by comparing retention times and peak heights to known standards.
Intracellular glutathione concentrations. Intracellular glutathione concentrations were depleted by addition of buthionine sulfoximine (BSO, 0.2 mM final concentration from a stock solution of 20 mM in water) or were elevated by addition of 2-oxothiazolidine-4-carboxylate (OTZ, 10 mM final concentration from a stock solution of 100 mM in 0.1 M Tris, pH 7.5) (17) . Intracellular concentrations of glutathione were quantitated by flow cytometry utilizing monochlorobimane as previously described (18) . Briefly, cells were incubated with 20 JAM monochlorobimane for 10 min and analyzed by flow cytometry using a dual-laser EPICS V (Coulter Electronics, Inc., Hialeah, CA). Cells were excited with 50 mW UV and mean cellular fluorescence was calculated numerically.
Extraction and measurement of intracellular NAD and A TP. Tumor cells (1 x 106) were washed once in PBS and suspended in 0.5 M perchloric acid (100 Ml) at 0-4°C. Lysates were clarified by centrifugation, neutralized with 1 M potassium hydroxide, and frozen at -20°C for 1-4 d. NADH was completely degraded under these conditions. Intracellular concentrations of NAD were determined with an enzymatic cycling assay which was linear between 3 and 100 pmol NAD (19) . Each well ofa 96-well microculture plate contained 50 MAl of either cell extract or NAD standard, 20 Ml of alcohol dehydrogenase (160 U/ml), and 150 Ml of a mixture of 600 mM ethanol; and 0.5 mM methyl thiazolyl tetrazolium, 2 mM phenazine ethosulfate, 5 mM ethylenediaminetetraacetic acid, 1 mg/ml bovine serum albumin, and 120 mM N-bis(2-hydroxyethyl)glycine, pH 7.8, essentially as previously described. Plates periods with the cytochrome c reduction assay essentially as previously described (20) . Release of superoxide anion as measured by reduction of cytochrome c was linear for up to 3 h and was inhibited by addition of superoxide dismutase. Release of H202 was determined by measuring horseradish peroxidase-catalyzed oxidation of scopoletin essentially as previously described (21) using a microtiter plate-reading fluorometer.
Assay of ADP-RT activity. Cells (2-5 X 106, 2 X 105/ml) were cultured in the presence or absence of IFN-'y, removed from tissue culture plates with a tissue scraper, and harvested by centrifugation at 10,000 g for lO s. Cells were washed once in PBS and were suspended in 500 ,u of 56 mM Hepes, pH 7.5, containing 28 mM KCI, 28 mM NaCl, 2 mM MgCl2, 0.01% digitonin, and 250 uM NAD (0.5 ACi/ml
[3H]NAD) essentially as previously described (22) . The amount of digitonin employed to permeabilize cells allowed uptake oftrypan blue but did not lead to release of intracellular organelles (23 
Results
Comparison ofsensitivity ofdifferent tumor cell lines to growth inhibition by IFN-Ty. Several different human tumor cell lines were evaluated to compare their relative sensitivity to growth inhibition by IFN-y. As shown in Fig. 1 , ME 180 cells and A549 cells were inhibited by 75-80% on day 3 by 30-300 U/ml IFN-'y whereas HT29, BT20, and MRC5 cells were inhibited by 55%, 0%, or 5%, respectively, by 1,000 U/ml IFN-'y. Addition of up to 10,000 U/ml IFN-'y did not increase growth inhibition of HT2;, BT20, or MRC5 cells in the 3-d assay. Culture of these cells for 6 d in the presence of IFN-y increased susceptibility of ME 180 and A549 cells to inhibition by IFN-'y. Concentrations of 100-300 U/ml IFN-y inhibited growth of BT20 cells in a 6-d assay ( IFN-y may inhibit tumor cell growth through an oxidative mechanism. A reduction in the concentration of oxygen would be expected to have a variety of effects on different cellular processes. It would also reduce the amount or number of oxygen species able to be produced by a cell or tissue. As shown in Table II , several antioxidants also prevented growth inhibition of the ME 180 cell line by IFN-'y in a 3-d assay.
Of the antioxidants tested, [B-mercaptoethanol and phenylbutazone increased cell growth in the presence of IFN-,y from 24% of control to 82% and 83% of control, respectively, for the ME180 cell line, ascorbate increased cell growth to 52% of control and dimethyl sulfoxide and vitamin E were minimally effective at preventing inhibition. Phenylbutazone or #l-mercaptoethanol could be added 24 h after addition of IFN-'y and still block inhibition. Phenylbutazone is also considered a non- steroidal anti-inflammatory agent and is co-oxygenated by the peroxidase activity of prostaglandin H synthetase (27) . Of the cell lines tested, ME180 and A549 responded similarly to the presence of antioxidants. Inhibition ofgrowth ofthe BT20 cell line by IFN-y was not affected by addition of these antioxidants. Taken together, these data suggest that IFN-y may mediate inhibition of growth of some tumor cell lines through an oxidative mechanism. Potential role of oxidant formation in IFN-'y activity. Reduced oxygen species such as superoxide anion or hydrogen peroxide mediate cellular damage of various types in certain systems. Results in Table III show that tumor cells cultured with IFN--y released elevated amounts of superoxide anion. The two cell lines, ME 180 and A549, increased release of superoxide anion by four-to fivefold after culture with IFN-y for 24-48 h. The two cell lines, BT20 and HT29, did not increase release of superoxide anion after culture with IFN-'y. This was true regardless ofthe concentration of IFN-y or the incubation period employed. Table IV shows that one ofthe antioxidants which blocked growth inhibition by IFN-'y, 2-mercaptoethanol, also blocked IFN-y-stimulated superoxide anion release in these same (28) . Thus it seemed possible that changes in intracellular glutathione might affect the activity of IFN-'y against certain tumor cell lines. These data are shown in Fig. 3 . The percentage of control cell growth (ME 180) is 20-30% in the presence of 10-30 U/ml IFN-'y in a 3-d culture. BT20 cells are inhibited by 100-300 U/ml IFN-'y in a 5-7-d culture. Elevation of glutathione levels by 10 mM OTZ increased growth in the presence of 100 U/ml IFN-'y from 10% to 65% for BT20 cells and from 30% to 85% for ME180 cells in the presence of 10 U/ml IFN-y. Conversely, reduction of glutathione levels with 0.2 mM BSO decreased growth of BT20 cells in the presence of 30 U/ml IFN-'y from 60% to 10% of control and decreased growth of ME 180 cells in the presence of 3 U/ml IFN--y from 90% to 50% of control. Addition of BSO or OTZ to cultures 24 h after addition of IFN-y also increased or decreased respectively, the sensitivity of tumor cells to inhibition but to a lesser degree.
Addition of IFN-'y alone to either BT20 cells or ME 180 cells did not alter intracellular glutathione concentrations even late in the culture period when cell growth was completely inhibited. In the presence of BSO, intracellular glutathione levels were decreased by 75-80% throughout the 6-d culture of BT20 cells whereas intracellular concentrations of glutathione were only decreased during the first 24 h of the culture of ME 180 cells. Addition of OTZ increased glutathione concentration by 20-50% but this increase was transient and glutathione concentration decreased to control levels within 24 h (data not shown). Sensitivity of other cell lines to inhibition by IFN-y was also affected by raising or lowering intracellular glutathione concentration. The greatest effects were seen with BT20 and SKCO1 cells. HT29 and ME 180 cells were less affected and A549 cells were least affected by addition of BSO or OTZ. These differences paralleled the degree of change in glu- IFN-y (data not shown) . Also, it was necessary to add BSO or OTZ early in the culture period to alter sensitivity of the various cell lines to inhibition by IFN-'y.
Tryptophan prevents IFN-y-mediated inhibition oftumor cell growth. As shown in Fig. 4 , addition of tryptophan prevented inhibition of cell growth by IFN-y. The concentration ofIFN-'y required to yield 50% inhibition ofgrowth by ME 180 cells was 3 U/ml in the absence of added tryptophan but was 700 U/ml in the presence of 1 X IO-' M tryptophan. Increased concentrations of tryptophan increased the amount of IFN-,y necessary to achieve equivalent inhibition ofgrowth ofME 180 cells. The titration of inhibition of growth vs. IFN-'y concentration in the presence of increasing tryptophan concentrations yielded a series of almost parallel curves. These data are portrayed in Fig. 4 (inset) as the log of the dose of IFN-'y required to yield 50% inhibition vs. the log of the concentration of tryptophan. The log ofthe ID50 was proportional to the log of the tryptophan concentration in the media as the tryptophan concentration was increased.
Results shown in Table VI indicate that the ability to inhibit IFN-y activity was specific for L-tryptophan. Several other aromatic amino acids such as tyrosine, phenylalanine, or histidine or other essential amino acids such as methionine, isoleucine, or lysine at similar concentrations (5 X 10-4 M) did not affect IFN-y-mediated inhibition of growth of ME180 cells. In addition, D-tryptophan failed to protect against the inhibitory effects of IFN-y at concentrations which were 10-fold greater than concentrations of L-tryptophan which showed partial protection.
The addition of L-tryptophan did not prevent IFN-y-mediated inhibition ofcell growth by all tumor cell lines. Further, the addition ofL-tryptophan did not prevent growth inhibition of ME 180 cells by TNF-a (data not shown). The two cell lines Amino Acid (pM) Figure 6 . Production of kynurenine by cells exposed to IFN-,y. The product of oxidation of tryptophan by either indoleamine 2,3-dioxygenase or tryptophan 2,3-dioxygenase is formylkynurenine (13) . Most cells also have kynurenine formamidase which produces kynurenine from formylkynurenine. ME 180 cells (1 X 105/ml) were cultured with or without 10 or 100 U/ml IFN-,y in complete media. After 48 h, cells were washed and cultured in RPMI-1640 medium without amino acids except 100 or 500 AM tryptophan in dialyzed fetal calfserum. Culture media was harvested after 6 or 24 h, filtered, and analyzed for tryptophan and kynurenine concentrations by amino acid analysis. After 6 or 24 h of culture, cells not exposed to IFN-y had produced no kynurenine and tryptophan concentration in the media was unchanged. Media (100 ,M tryptophan) from cells exposed to 10 U/ml IFN-y had a tryptophan concentra-tion of 70 ,uM after 6 h and 30 MM after 24 h. The kynurenine concentration was 20 MM after 6 h and 50MAM after 24 h. More kynurenine (150 MM after 24 h) was produced from cells cultured in 500 MM tryptophan than in 100 MM tryptophan.
Inhibitors ofIFN-'y activity also prevent loss oftryptophan. Phenylbutazone and 2-mercaptoethanol prevent growth inhibition of ME180 and A549 cells mediated by IFN-'y. These agents, at concentrations which inhibit IFN-y activity, also prevent the loss of tryptophan from media (Fig. 7) . ME180 or A549 cells were cultured in the presence of 3-30 U/ml IFN-,y in the presence or absence of phenylbutazone or 2-mercaptoethanol. Culture media was harvested after 48 h. In the presence of IFN-'y, loss oftryptophan from cultures of ME 180 and A549 cells was almost complete. Loss of tryptophan was almost completely inhibited in the presence of phenylbutazone or 2-mercaptoethanol.
Inhibitors ofADP-RT block IFN-y-mediated inhibition of cell growth. Inhibition of growth of several other cell lines was unaffected by addition of tryptophan and these cells did not deplete media of tryptophan when cultured with IFN-'y. On the basis of these results, it was apparent that IFN-y inhibited tumor cell proliferation by at least one additional mechanism dependent upon oxygen concentration. Activation of intracellular ADP-RT by agents that cause DNA strand breaks leads to inhibition of cell growth or loss in cell viability (12) . Reactive oxygen species have been shown to mediate the DNA strand breaks caused by a wide variety of agents (14) . Two inhibitors of ADP-RT, 2-aminobenzamide and nicotinamide, prevent ADP ribosylation of proteins, the loss in NAD, and inhibition of cell growth or loss in cell viability caused by activation of ADP-RT (29) . As shown in Fig. 8 , inhibition of growth of BT20 cells by IFN-'y was blocked by addition of 10 mM nicotinamide or 10 mM 3-aminobenzamide. Under these conditions, nicotinamide or 3-aminobenzamide did not affect growth of BT20 cells in the absence of IFN-,y. Increased concentrations of ADP-RT inhibitors inhibited the growth of BT20 cells and lower concentrations of ADP-RT inhibitors were less effective at blocking the inhibitory activity of IFN-'y.
Other cell lines employed in these studies were also tested for sensitivity to growth inhibition by IFN-'y in the presence or absence of ADP-RT inhibitors. These results are shown in Table VIII . Growth inhibition of ME180 and A549 was not affected by addition of ADP-RT inhibitors. By contrast, inhibition ofgrowth ofthose cell lines (BT20, HT29, and SKLU 1), IFNy (U/ml) which did not appear to employ catabolism of tryptophan as a mechanism ofinhibition, was blocked by addition ofADP-RT inhibitors. Inhibition of growth of one cell line, SKCO1, by IFN-'y was not affected by addition of either tryptophan or inhibitors of ADP-RT. Activation of ADP-RT is known to result in the ADP ribosylation of intracellular proteins and has been shown to result in the elimination of intracellular NAD (30) . Inhibitors of ADP-RT such as 3-aminobenzamide or nicotinamide have been shown to prevent depletion ofNAD (13, 19) . As shown in Table IX (51) . § The numbers in parentheses indicate percent of control NAD levels.
( Fig. 5) . Inhibitors of IFN-y activity also prevented the loss of intracellular NAD. These data are shown in Table X. ME180 and A549 cells which are protected from IFN-y-mediated growth inhibition by tryptophan also did not lose intracellular NAD in the presence of additional tryptophan. Inhibitors of ADP-RT did not prevent the loss ofNAD in these cell lines. By contrast, inhibitors of ADP-RT prevented both inhibition of cell growth and loss of intracellular NAD in BT20 and HT29 cell lines whereas addition of tryptophan failed to prevent growth inhibition as well as loss of NAD in these cell lines.
Levels of intracellular ATP were also lower in IFN-'ytreated cells. Control ME 180 cells had 26 nmol ATP/mg pro- (33) . Activity of IFN-'y against all tumor cell lines tested was significantly reduced by decreasing oxygen concentration. By contrast, inhibition of cell division (ME 180) by TNF-a was unaffected by low oxygen concentration. The synergistic antiproliferative activity of TNF-a and IFN-y against BT20 cells was also inhibited by reducing oxygen concentration (15% of control cell growth with 10 U/ml TNF-a plus 30 U/ml IFN-'y in the presence of 20% oxygen vs. 45% of control cell growth or 70% of control cell growth in the presence of 12% or 4% oxygen, respectively). Reduced oxygen tension also slowed the growth rate of these tumor cells. Thus it is possible that the reduced effect of IFN-y is simply associated with the reduced growth rate. However, the response of ME180 cells to TNF-a was unaffected by reduced oxygen tension even in the presence of a slower growth rate. Further, a variety of agents such as TNF-a, actinomycin D, or cycloheximide, which slow the growth rates of certain mammalian cells, enhance rather than reduce the ability of IFN-'y to inhibit cell growth. This supports the notion that the reduced effectiveness of IFN-y in the presence oflower oxygen tension may be relatively specific. The results discussed below point to specific mechanisms of IFN-y-mediated inhibition of cell growth which may require reduced species of molecular oxygen.
High concentrations of molecular oxygen are relatively toxic to cells (34) . Certain agents that inhibit cell growth appear to do so by generating reactive species or free radicals of oxygen (35, 36) . It has been demonstrated that intracellular concentrations of reduced glutathione play an important role in the protection of cells to oxidizing or ionizing species. Raising or lowering glutathione levels decrease or increase sensitivity of cells to a variety of agents including peroxide, activated macrophages or granulocytes, ionizing radiation, elevated temperatures, ethanol, and several antineoplastic agents (37 (28) .
Catalase and superoxide dismutase have also been implicated in the cellular defense mechanism against oxidizing species. The tumor cell lines employed in these studies had similar concentrations of catalase (2.2-3.0 U/mg protein) and undetectable amounts of superoxide dismutase (38 ) Inhibitors of ADP-RT activity did block both the loss of intracellular NAD and cellular toxicity associated with activation of ADP-RT. In these cell lines (BT20 and HT29) addition of tryptophan did not prevent loss of intracellular NAD or cellular toxicity mediated by IFN-'y.
NAD primarily exists in the oxidized form within tissues and eukaryotic cells. Since the method for extraction of NAD employed in these studies does not preserve NADH, it is possible that some of the observed decrease in NAD could result from a shift from the oxidized to the reduced pool of NAD. Results presented here suggest that depletion of intracellular NAD represents a common denominator of IFN-y-mediated inhibition of tumor cell growth. Intracellular levels of ATP also fell .after culture of tumor cells with IFN-y. Depletion of ATP after DNA damage has been shown to be secondary to depletion of NAD (45) . Thus the fall in NAD may result in inhibition of glycolysis as well. Additionally, depletion of NAD through the formation of protein-bound ADP-ribose may result in the depletion of ATP through synthesis of NAD from nicotinamide mononucleotide (14) .
Activity of ADP-RT is also involved in cellular differentiation and inhibitors of ADP-RT inhibit myoblast differentiation and the expression of fetal functions by adult hepatocytes in tissue culture (46, 47) . Inhibitors of ADP-RT also prevent mitogen-induced activation and proliferation of human lymphocytes (48) . The activity of this enzyme must be well regulated if its activation can lead to loss of cell viability in one instance and the expression of differentiated function without loss of cell viability in another instance. It is interesting to note that IFN-y has been shown to cause inhibition of cell growth and loss of viability of certain tumor cell lines in some instances and also to stimulate the expression of differentiated functions by other cell types in the absence of loss of cell viability (2) .
It is unclear whether increases in oxygen concentration or decreases in intracellular glutathione content will alter the activity of IFN-y against tumor cells in vivo. Humans or animals excrete tryptophan oxidation products such as kynurenine after administration of IFN-'y (49, 50 Finally, experiments presented here as well as elsewhere (8, 9) suggest that there may be a fundamental difference between the way nontransformed and transformed cell lines respond to IFN-'y. Both normal and transformed cells can respond to IFN-y by increasing levels of indoleamine 2,3-dioxygenase.
However, transformed cells also respond by lowering levels of intracellular NAD and inhibiting cell growth. By contrast, the normal diploid lung fibroblast line, MRC5, does not lose intracellular NAD or slow its growth rate in the presence ofNAD even though the media is depleted of tryptophan. Therefore, nontransformed and transformed cells may differ in their requirements for tryptophan. This appears to be the case. The half-maximal growth rate of normal lung diploid cells (MRC5 and IMR90) or mitogen-activated human peripheral blood lymphocytes is obtained with 3 ,M tryptophan (range of [2] [3] [4] [5] MuM) and the half-maximal growth rate of several human tumor cell lines (ME 180, A549, HT29, SKLU1, SKCO 1, or BT20) is obtained with 36 MM (range of 25-50 gM). This difference may be unique to tryptophan. The change in the growth rates ofthese same normal and transformed cell lines is similar in the presence of varying concentrations of methionine or leucine, two other essential amino acids. This may be important when considering the properties of normal and transformed cells.
